Stock ATRINSIC, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Insiders Atrinsic, Inc. Other OTC

Equities

US04964C2089

End-of-day quote Other OTC
Other stock markets
- USD - Intraday chart for Atrinsic, Inc.
05-15 Protagenic Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-01 Protagenic Therapeutics, Inc. Completes Enrollment in Single Dose Portion of Phase 1 of Innovative Stress Disorder Trial CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Protagenic Therapeutics, Inc. Appoints Timothy R. Wright as a Class I Director
CI
Protagenic Therapeutics, Inc. Announces Audit Committee Changes
CI
Protagenic Therapeutics, Inc. Appoints Jennifer Buell as a Member of the Board
CI
Protagenic Therapeutics, Inc. Announces Board Changes
CI
Protagenic Therapeutics, Inc. Announces Resignation of Gregory K. Ekizian as Director and Chairman of the Audit Committee
CI
Atrinsic, Inc. Creases Robert Ziroyan as Interim President and Chief Operating Officer
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PTIX Stock
  4. Stock
  5. News Atrinsic, Inc.
  6. Insiders